Gijs F. N. Berkelmans

Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus

Gijs F. N. Berkelmans, Soffia Guðbjörnsdóttir, Frank L.J. Visseren et al. · European Heart Journal · 2018 · 86 citations · Full text

Comparing volume-clamp method and intra-arterial blood pressure measurements in patients with atrial fibrillation admitted to the intensive or medium care unit

Gijs F. N. Berkelmans, Sanne Kuipers, Berend E. Westerhof et al. · Journal of Clinical Monitoring and Computing · 2017 · 33 citations · Full text

Mediation analysis of the relationship between type 2 diabetes and cardiovascular events and all‐cause mortality: Findings from the SMART cohort

Shahnam Sharif, Rolf H. H. Groenwold, Yolanda van der Graaf et al. · Diabetes Obesity and Metabolism · 2019 · 33 citations · Full text

Limited benefit of haemoglobin glycation index as risk factor for cardiovascular disease in type 2 diabetes patients

Helena Bleken Østergaard, Thomas Mandrup‐Poulsen, Gijs F. N. Berkelmans et al. · Diabetes & Metabolism · 2018 · 32 citations

Metabolic Syndrome, Hypertension, Cardiovascular Disease +9

Decline in risk of recurrent cardiovascular events in the period 1996 to 2014 partly explained by better treatment of risk factors and less subclinical atherosclerosis

Gijs F. N. Berkelmans, Yolanda van der Graaf, Jannick A N Dorresteijn et al. · International Journal of Cardiology · 2017 · 20 citations · Full text

Vascular Disease, Cardiovascular Epidemiology, Health Policy +10